SCHEMBL21481652

SCHEMBL21481652

c1ccc(-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2ccc3c(c2)c2ccccc2n3-c2ccc3c(c2)sc2ccccc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.50
ATM Q13315 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 5/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GPR3 P46089 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
GAA P10253 2/20 0.35
PTPN1 P18031 2/20 0.32
PDE1B Q01064 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
HDAC4 P56524 1/20 0.32
PMM2 O15305 1/20 0.32
IDE P14735 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228186 0.97 L3MBTL1 (0.53) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL27428319 0.96 ATM (0.51) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL17246309 0.94 ATM (0.50) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL21481278 0.93 ATM (0.46) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL27428458 0.93 ATM (0.51) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL19342694 0.93 ATM (0.51) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL17245448 0.93 L3MBTL1 (0.51) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL10450790 0.93 MAPT (0.46) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL17189517 0.93 MAPT (0.46) L3MBTL1ATMKDM4EALDH1A1MAPT
SCHEMBL14822628 0.92 ATM (0.50) L3MBTL1ATMKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE PIEZO1, OR10J3, OR51E2 L3MBTL1 1968/4885ATM 2334/4885KDM4E 2904/4885
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF AOX1, ODC1, OTC L3MBTL1 2702/4885ATM 2511/4885KDM4E 4036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.